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Abstract:  The proliferative potential of a spinal nephroblastoma was studied in a young dog.  A 4-month-old, female
golden retriever showed developing deterioration in her gait and subsequent paralysis of her hind legs.  At necropsy, a
well-demarcated grayish brown tumor mass was found in the lumbar spinal cord segments between L2 and L3.
Histologically, a blastemal cell tumor with a tubule- or glomeruli-like structure was found to be infiltrating intradurally.
Proliferating cells at the S-phase, assessed using the bromodeoxyuridine (BrdU) labeling method, were seen occasionally
in the tubular cells and glomeruli-like structures and were frequently seen in the blastemal cells.
Immunohistochemically, the tubular epithelial cells were positive for cytokeratin, and the blastemal cells were positive
for vimentin.  The present tumor showed a high potential for growth and invasion, which suggests that it the potential
to expand into the adjacent spinal cord.   (J Toxicol Pathol 2009; 22: 79–82)
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Spinal nephroblastoma is unusual and has rarely been
reported in juveniles and young dogs of the German
shepherd breed, which are predisposed to such tumors1–5.
Occurrence of this tumor is not well established in animals
except for dogs6,7.  To date, the histogenesis of this neoplasm
has been controversial, and this tumor is currently thought to
be an extrarenal nephroblastoma based on its histological
features as well as immunohistochemistry3,7.  Spinal
nephroblastomas likely develop from the remnants of renal
rests trapped between the dura and the developing spinal
cord1,2,5,7.  Regarding the biological behavior of this tumor,
little information is available except for a report of an
aggressive neoplasm giving rise to a second, less
differentiated metastatic focus5.  We endeavored to assess
the proliferative potential of a spinal nephroblastoma in a
young dog.
A 4-month-old female golden retriever dog was
admitted to a veterinary hospital because of deterioration in
her gait and the X-appearance of her hind legs.  Physical
examination confirmed symmetrical paralysis, and a
myelogram showed an intradural mass in the spinal cord
from the level of L2 to L3 (Fig. 1).  The tumor was resected
surgically two months after admission.  At the time of
surgery through a long midline incision, an encapsulated,
intradural grayish brown tumor mass was found in the spinal
cord in the L2 to L3 region.  Histopathological examination
of the operative specimen revealed a suspected
ependymoma.  Postoperatively, the dog did not recover well;
the tumor recurred at the site of the operation, and the dog
was euthanized because of poor general condition three
months after the operation.
The dog was euthanized by deep anesthesia.  A gross
examination revealed a subdural lobular mass measuring
6×5×1 mm in the spinal cord at the levels of L2 and L3.  The
capsular surface was reddish-gray and was covered with
thick fibrous connective tissue.  The cut surface contained
grayish yellow medullary tissue with gelatinous and
hemorrhagic areas.  It was quite firm and resilient (Fig. 2).
A complete necropsy was performed immediately.
Tissue and organ samples were collected and fixed in 10%
buffered formalin.  After fixation, tissue blocks were
dehydrated and embedded in paraffin wax in the usual
manner.  Sections with a thickness of 3 μm were stained with
hematoxylin-eosin (HE).
For immunohistochemistry, the labeled strepto-avidin-
biotin (LSAB) method was applied to deparaffinized
sections using a commercial kit (DAKO Corp., Santa
Barbara, CA, USA).  The primary antibodies used were anti-
keratin, S-100, glial fibrillary acidic protein (GFAP),
neuron-specific enolase (NSE; polyclonal, DAKO Corp.),
anti-cytokeratin AE1/AE3 (monoclonal, Signet labs, Inc.,
Dedham. MS, USA) and anti-vimentin, (monoclonal,
DAKO Corp.).  The deparaffinized sections were incubated
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successively in normal goat serum and each primary
monoclonal antibody overnight at 4°C and were then
incubated in biotinylated anti-mouse immunoglobulin G at
room temperature for two hours.  The sections were
subsequently incubated in PBS containing 0.03% 3.3’-
diminobenzidine (DAB; Dojin Chemical Company,
Kumamoto, Japan) and 1%H2O2 and then counterstained
with Mayer’s hematoxylin.  Negative and substituted serum
controls and positive tissue controls were also employed.
To assess the proliferative activity, bromodeoxyuridine
(BrdU) (Sigma Chemical Co., St. Louis, MO, USA) was
administered intravenously at a dose of 15 mg/kg one hour
prior to euthanasia.  BrdU-incorporated cells were identified
by immunohistochemical techniques using the LSAB
method on deparaffinized sections and a commercial kit with
anti-BrdU antibody (monoclonal, Immunotech S.A.,
Marseilles, France).  The deparaffinized sections were
incubated successively in a 1:4,000 dilution of a BrdU
monoclonal antibody overnight at 4°C and then in
biotinylated anti-mouse immunoglobulin G at room
temperature for two hours.  The sections were then incubated
in PBS containing 0.03% DAB and l% H2O2 and
counterstained with Mayer’s hematoxylin.  BrdU-positive
nuclei exhibited deposits of brown DAB precipitates.  The
BrdU labeling index (LI) was determined by counting 200
cells.  The BrdU LI was expressed as a percentage of the
total number of labeled cells scored.
For electron microscopy, tissue samples from the tumor
mass in the spinal cord were fixed with 2% phosphate-
buffered glutaraldehyde and 1% osmium tetroxide and
routinely processed.  Ultrathin section were cut, stained with
uranyl acetate and lead citrate and examined with a Hitachi
H-8100 electron microscope at 75 kV.
There was infiltrative cellular tumor growth at the level
of L2 and L3 in the spinal cord, and this resulted in subdural
compression of the adjacent spinal parenchyma (Fig. 3).  The
tumor was composed of fusiform or round cells with
hyperchromatic nuclei and scanty cytoplasm and closely
resembled an embryonic metanephrotic blastema.  Epithelial
tubules of various sizes lined with cuboidal and columnar
cells were frequently observed in the clusters or nests of
densely packed blastemal cells.  Structures resembling
immature glomeruli, which are a papilloferous formation of
blastemal cells within a cystic space, were observed (Fig. 4).
Mitotic figures were prominent among the cells of the
blastemal components and were less frequently observed in
the tubules with epithelial components.  The nests of
blastemal cells were separated by various amounts of
connective tissue.  The spindle and stellated cells
accompanying stromal connective tissue had evolved from
the round cells of richly cellular blastomous masses, and
transitional elements were obvious.  The boundary between
the tumor and spinal cord tissue was well circumscribed.
Fibrous connective tissue was present, and a few foci tumor
cells, constituting small tubules, were seen in the
parenchyma adjacent to the tumor.  A circumscribed area of
cartilage, which is normally uncommon, was found in the
present case.  No teratogenic components were encountered
in the tumor.
Immunohistochemical evaluation revealed consistent
positive reactions for keratin (Fig. 5) and cytokeratin AE1/
AE3 in the epithelial cells and vimentin in the blastemal
cells.  Other markers (S-100 protein, NSE and GFAP) were
negative in both elements.
Ultrastructurally, both the epithelial and blastemal
tumor cells had oval or elongated nuclei.  Cytoplasmic
organelles were poorly developed; however, numerous free
ribosomes, a few rough endoplasmic reticula and small
round mitochondria were observed.  The epithelial cells had
abundant junctional complexes and formed conspicuous
lumina and microvilli.  The basal sides of the epithelial cells
were underlined by basement membrane-like materials.
Junctional complexes were observed between the epithelial
cells on the luminal side.
Immunostaining for BrdU showed only an occasional
labeled nucleus in the tubular epithelial cells and frequent
positive cells in the nests of blastemal cells (Fig. 6).  The
BrdU LI was no less than 2% in epithelial cells and was
11.8% in blastemal cells, respectively.
It appears that the present tumor satisfies the criteria for
an intradural extramedullary spinal cord tumor in young
dogs, as reported by Summers et al.4.  Previously, intradural
spinal cord tumors in young dogs have been interpreted as
ependymoma8 or neuroepithelioma9.  It is now believed that
this tumor arises within the embryonic rest of renal tissue in
the spinal cord, and it has been suggested that it is an
extrarenal nephroblastoma in the spinal cord6,7.  Because
there was no renal neoplasm at a clinical examination, the
present spinal cord tumor was obviously the primary tumor.
The most striking morphological feature of the present tumor
was the mix of blastematous, epithelial and stromal
elements, which closely resembled the characteristics of a
differentiated nephroblastoma in the kidney4,7.  In humans,
extrarenal nephroblastomas are occasionally seen in various
locations such as the pelvis and female reproductive
organs14–16.  The extrarenal location increases the likelihood
that these tumors originate over a wide area from remnants
of undifferentiated mesodermal tissue before the
mesodermic derivatives of myotome, sclerotome and
nephrotome develop14.  Most nephroblastomas originating
from the kidney pose few diagnostic difficulties, but those of
extrarenal origin are frequently difficult to diagnose and
require ultrastructural or immunohistochemical
identification of some epithelial feature in order to confirm
the diagnosis4,6,7.
The proliferative potential of the present tumor was
assessed by BrdU immunohistochemistry.  BrdU is a
thymidine analogue that is incorporated into DNA-
synthesizing nuclei (S-phase), and the incorporated BrdU in
the nuclei can be detected using antibodies against BrdU12.
The BrdU LI correlates well with the proliferative potential
of neoplasms, such as meningioma, astrocytoma and
glioblastoma multiforms13.  Nephroblastoma is a highly
malignant type of tumor found in human juveniles andOhta, Kobayashi, Sakai et al. 81
Fig. 3. Expansive tumor growth compressing the spinal parenchyma.
Note the multiple nests of blastemal cells surrounded by
stellated neoplastic stromal cells.  HE stain.  Bar=200 μm.
Fig. 2. Cut surface of spinal mass between the spinal cord at the
second to third lumbar vertebrae.  Neoplastic tissues
compressed the spinal parenchyma (arrows).  Bar=5 mm.
Fig. 1. Lumbar spinal cord myelogram.  Arrows delineate an area of
widening of the spinal cord extending from the second to third
lumbar vertebrae.
Fig. 4. Frequent tubular epithelial cells were seen in the blastemal
component.  The mass is composed of three distinct elements,
dense sheets of polygonal blastemal cells, a delicate fibrous
supporting stroma and an epitheloid component forming
tubules and structures resembling fetal glomeruli (arrows).
HE stain.  Bar=50 μm.
Fig. 5. Tubular epithelial cells are positive for keratin by
immunohistochemical staining.  Bar=50 μm.
Fig. 6. Immunostaining for BrdU.  Many labeled nuclei are seen in
the blastemal cells, and there are also occasional labeled cells
in the tubular epithelial cells.  Bar=100 μm.82 Spinal Nephroblastoma in a Young Dog
animals and tends to recur rapidly after surgical removal7,10.
The present tumor showed a higher BrdU incorporated index
(11.8%) in the blastemal components, and this is roughly
equal to those of malignant tumors such as squamous cell
carcinomas11, mammary carcinomas and grade III
masctocytomas17.  As the present tumor contained many
BrdU labeled cells with a higher BrdU LI, the present tumor
was considered to be malignant and to have the potential for
recurrence.
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